SMS Pharmaceuticals
248.25
-2.45(-0.98%)
Market Cap₹2,222.50 Cr
PE Ratio31.80
IndustryHealthcare
Company Performance:
1D-0.98%
1M-4.56%
6M-3.28%
1Y+0.76%
5Y+291.87%
View Company Insightsright
Latest news about SMS Pharmaceuticals
SMS Pharmaceuticals Boosts Ownership in SMS Peptides to 99.98% 4 days ago
SMS Pharmaceuticals has raised its ownership in its subsidiary, SMS Peptides, from 93.00% to 99.98%. This strategic move strengthens SMS Pharmaceuticals' position in the peptides segment and allows for enhanced integration, strategic alignment, and financial consolidation. The increased stake demonstrates the company's commitment to consolidating control over SMS Peptides and positions it to capitalize on emerging opportunities in the growing peptide-based pharmaceuticals market.
SMS Pharma's Central Laboratory Aces USFDA Inspection 6 days ago
SMS Pharma Receives FDA Clearance for Hyderabad Facility May 30, 2025
SMS Pharma Reports Strong Q4 Results with Improved EBITDA and Net Profit May 30, 2025
SMS Pharma's Vizag Plant Achieves WHO Prequalification, Boosting Global Market Prospects May 02, 2025
More news about SMS Pharmaceuticals
24Mar 25
SMS Pharmaceuticals Concludes USFDA Inspection at Hyderabad API Facility with Minor Observation
SMS Pharmaceuticals' API manufacturing facility in Hyderabad, Telangana, has undergone a USFDA inspection. The inspection concluded with Form 483 issued, containing only one observation. This outcome is generally viewed positively in the pharmaceutical industry, suggesting the company's manufacturing practices largely align with U.S. regulatory standards. SMS Pharmaceuticals will need to respond to the observation and provide a plan to address the issue. The nature and severity of the observation remain undisclosed.
SMS Pharmaceuticals
248.25
-2.45
(-0.98%)
1 Year Returns:+0.76%
Industry Peers
Sun Pharmaceutical
1,667.20
(-0.51%)
Divis Laboratories
6,856.50
(+0.69%)
Cipla
1,515.70
(+0.65%)
Torrent Pharmaceuticals
3,416.70
(+0.25%)
Dr Reddys Laboratories
1,276.80
(-0.51%)
Zydus Life Science
1,002.50
(+1.27%)
Mankind Pharma
2,287.00
(-1.41%)
Lupin
1,960.90
(+1.18%)
Abbott
34,665.00
(-2.82%)
Aurobindo Pharma
1,132.50
(-0.20%)